Diabetes, Vol 47, Issue 9 1392-1398, Copyright © 1998 by American Diabetes Association
Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage
S Baque, E Montell, JJ Guinovart, CB Newgard and AM Gomez-Foix
Department de Bioquimica i Biologia Molecular, Universitat de Barcelona, Spain.
Insulin resistance, as is found in skeletal muscle of individuals with
obesity and NIDDM, appears to involve a reduced capacity of the hormone to
stimulate glucose uptake and/or phosphorylation. The glucose
phosphorylation step, as catalyzed by hexokinase II, has been described as
rate limiting for glucose disposal in muscle, but overexpression of this
enzyme under control of a muscle-specific promoter in transgenic mice has
had limited metabolic impact. In the current study, we investigated in a
cultured muscle model whether expression of glucokinase, which in contrast
to hexokinase II is not inhibited by glucose-6-phosphate (G-6-P), would
have a pronounced metabolic impact. We used a recombinant adenovirus
containing the cDNA-encoding rat liver glucokinase (AdCMV-GKL) to increase
the glucose phosphorylating activity in cultured human muscle cells by
fourfold. G-6-P levels increased in AdCMV-GKL-treated cells in a glucose
concentration-dependent manner over the range of 1-30 mmol/l, whereas the
much smaller increases in G-6-P in control cells were maximal at glucose
concentrations <5 mmol/l. Further, cells expressing glucokinase
accumulated 17 times more 2-deoxyglucose-6-phosphate than control cells. In
AdCMV-GKL-treated cells, the time-dependent rise in G-6-P correlated with
an increase in the activity ratio of glycogen synthase. AdCMV-GKL-treated
cells also exhibited a 2.5- to 3-fold increase in glycogen content and a
four- to fivefold increase in glycolytic flux, proportional to the increase
in glucose phosphorylating capacity. All of these observations were made in
the absence of insulin. Thus we concluded that expression of glucokinase in
cultured human muscle cells results in proportional increases in
insulin-independent glucose disposal, and that muscle glucose storage and
utilization becomes controlled in a glucose concentration-dependent manner
in AdCMV-GKL-treated cells. These results encourage testing whether
delivery of glucokinase to muscle in vivo has an impact on glycemic
control, which could be a method for circumventing the failure of insulin
to stimulate glucose uptake and/or phosphorylation in muscle normally in
insulin-resistant subjects.